1) Thrombus Associated Marker /drug effects
血栓相关分子标志物/药物作用
2) prethrombotic state molecular marker
血栓前状态分子标志物
1.
This study was aimed to investigate the dynamic changes of plasma prethrombotic state molecular marker levels during perioperation of patients and to provide laboratorial evidence for clinical diagnosis of these patients so as to take intervenient measure to high risk patients.
本研究旨在观察手术患者围术期血浆血栓前状态分子标志物的动态变化,为临床判断血栓前状态、对高危患者采取早期干预措施提供实验依据。
3) the markers of thrombosis
血栓标志物
1.
Objective To examine the changes of d-dimer(D-D) and von Willebrand factor(vWF),the markers of thrombosis in peripheral blood,as well as the expression of P-selectin(CD62P) and CD63,and the markers of platelet activation before and after thrombolytic therapy in acute myocardial infarction(AMI),along with their relationship to reperfusion of the coronary arteries.
目的探讨急性心肌梗塞患者溶栓前后外周血中血栓标志物(D-二聚体D-D,血管性假血友病因子vWF)水平变化和血小板活化状态标志物血小板α颗粒膜糖蛋白CD62P及溶酶体膜糖蛋白CD63的阳性表达率与血管再通的关系。
4) TXB_2/drug eff
血栓素B_2/药物作用
5) Thromboxane B 2/drug eff
血栓烷B2/药物作用
补充资料：溶菌酶分子及其作用底物(紫色)
[图]
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条